financetom
Business
financetom
/
Business
/
Market Chatter: Advent Nearing Deal to Buy Canadian Payments Processor Nuvei, source says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Advent Nearing Deal to Buy Canadian Payments Processor Nuvei, source says
Mar 17, 2024 5:40 PM

08:01 PM EDT, 03/17/2024 (MT Newswires) -- Private equity firm Advent International is in advanced talks to buy Nuvei ( NVEI ), a Canadian payments technology company that has received financial backing from actor Ryan Reynolds, a source familiar with the matter told Reuters on Saturday.

A deal could be announced soon, said the source, who asked not to be named because the discussions are confidential.

However, talks could still fall apart, the source added. The source did not reveal proposed terms of the deal.

Reuters noted Advent's buyout of Nuvei ( NVEI ), which has a market capitalization of more than US$3 billion, would make it one of the more sizable take-private deals at a time when private equity dealmaking has slowed.

The Wall Street Journal first reported about Advent's talks with Nuvei ( NVEI ) on Saturday.

Advent declined to comment, and Nuvei ( NVEI ) did not immediately respond to Reuters' request for comment.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Jan 7, 2025
ZURICH (Reuters) -Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a specialist in complex immune cell therapies to treat several types of blood cancer. Roche said it has accepted for payment nearly 65 million shares in Poseida - equivalent to 66% of the California company's stock - which had been tendered...
Roche to complete acquisition of U.S. biopharma company Poseida
Roche to complete acquisition of U.S. biopharma company Poseida
Jan 7, 2025
ZURICH, Jan 8 (Reuters) - Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics via its subsidiary Blue Giant Acquisition Corp. Roche said it has accepted for payment nearly 65 million shares in Poseida - equivalent to 66% of the California company's stock - which had been tendered by shareholders at a price...
Jim Cramer Sees Buying Opportunity In Nvidia But Attributes 6% Fall To 'Too Much Hot Money' After Jensen Huang's CES Keynote
Jim Cramer Sees Buying Opportunity In Nvidia But Attributes 6% Fall To 'Too Much Hot Money' After Jensen Huang's CES Keynote
Jan 7, 2025
Jim Cramer urged investors to consider NVIDIA Corp. ( NVDA )‘s recent stock decline as a buying opportunity, despite the company’s shares falling 6.22% on Tuesday following CEO Jensen Huang‘s CES 2025 keynote presentation. What Happened: “Understand one thing, the keynote dazzled, the new projects are way ahead of any other company, and this new industrial revolution belongs to Nvidia,”...
BRIEF-Roche Purchases Shares Of Poseida Therapeutics, Inc. In Tender Offer
BRIEF-Roche Purchases Shares Of Poseida Therapeutics, Inc. In Tender Offer
Jan 7, 2025
Jan 8 (Reuters) - ROCHE HOLDING AG: * ROCHE PURCHASES SHARES IN TENDER OFFER FOR POSEIDA THERAPEUTICS, INC. * ACCEPTS PAYMENT FOR POSEIDA SHARES AT $9.00 PER SHARE PLUS CVR * TENDER OFFER EXPIRED ON 7 JANUARY 2025, WAS NOT EXTENDED * APPROXIMATELY 64,991,586 SHARES OF POSEIDA TENDERED, REPRESENTING 66.11% OF OUTSTANDING SHARES * FOLLOWING COMPLETION OF MERGER, POSEIDA WILL...
Copyright 2023-2026 - www.financetom.com All Rights Reserved